Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Toxicology
|
January 15, 1997
Utilization of renal slices to evaluate the efficacy of chelating agents for removing mercury from the kidney
R L Keith, I Setiarahardjo, Q Fernando, et al.
Environmental Health Perspectives
|
December 5, 2000
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine
X C Le, M Ma, W R Cullen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1990
Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation
R M Maiorino, J M Akins, K Blaha, et al.
Analytical Chemistry
|
November 18, 2000
Speciation of key arsenic metabolic intermediates in human urine
X C Le, X Lu, M Ma, et al.
Life Sciences
|
November 8, 1982
Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid
H V Aposhian, M M Mershon, F B Brinkley, et al.
Toxicology and Applied Pharmacology
|
September 15, 1984
N-(2,3-dimercaptopropyl)phthalamidic acid: protection, in vivo and in vitro, against arsenic intoxication
E R Stine, C A Hsu, T D Hoover, et al.
Toxicology and Applied Pharmacology
|
July 1, 1999
Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes
R A Zakharyan, F Ayala-Fierro, W R Cullen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 15, 1999
The enigma of arsenic carcinogenesis: role of metabolism
P L Goering, H V Aposhian, M J Mass, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1993
Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat
R M Maiorino, M M Aposhian, Z F Xu, et al.
The Journal of Pediatrics
|
August 1, 1994
Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults
R C Dart, K M Hurlbut, R M Maiorino, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Toxicology
|
January 15, 1997
Utilization of renal slices to evaluate the efficacy of chelating agents for removing mercury from the kidney
R L Keith, I Setiarahardjo, Q Fernando, et al.
Environmental Health Perspectives
|
December 5, 2000
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine
X C Le, M Ma, W R Cullen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1990
Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation
R M Maiorino, J M Akins, K Blaha, et al.
Analytical Chemistry
|
November 18, 2000
Speciation of key arsenic metabolic intermediates in human urine
X C Le, X Lu, M Ma, et al.
Life Sciences
|
November 8, 1982
Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid
H V Aposhian, M M Mershon, F B Brinkley, et al.
Toxicology and Applied Pharmacology
|
September 15, 1984
N-(2,3-dimercaptopropyl)phthalamidic acid: protection, in vivo and in vitro, against arsenic intoxication
E R Stine, C A Hsu, T D Hoover, et al.
Toxicology and Applied Pharmacology
|
July 1, 1999
Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes
R A Zakharyan, F Ayala-Fierro, W R Cullen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 15, 1999
The enigma of arsenic carcinogenesis: role of metabolism
P L Goering, H V Aposhian, M J Mass, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1993
Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat
R M Maiorino, M M Aposhian, Z F Xu, et al.
The Journal of Pediatrics
|
August 1, 1994
Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults
R C Dart, K M Hurlbut, R M Maiorino, et al.
Page
of 8